纵向扩散张力成像与唐氏综合征中的粉样蛋白负担相关.
Lisette Gwendolyn LeMerise1, José Guerrero-Gonzalez1, Andrew McVea1
1Waisman Center, University of Wisconsin-Madison, Madison, Wisconsin, USA.
概括
唐氏综合征的成年人中的β粉样蛋白积累与随着时间的推移的白质变化有关. 扩散张力成像和粉样蛋白PET扫描是跟踪这些神经退行变化的敏感工具.
科学领域:
- 神经成像是一种神经成像.
- 神经退行性疾病 神经退行性疾病
- 唐氏综合征研究 唐氏综合征研究
背景情况:
- 与患有阿尔茨海默氏症 (AD) 的神经类型个体相比,患有唐氏综合征 (DS) 的成年人表现出加速的粉样β (Aβ) 斑块积累.
- 通过扩散张力成像 (DTI) 评估白质 (WM) 微观结构,可以在纵向研究中揭示神经退行变化.
- 这项研究探讨了AD连续性中DS患者的DTI指标和Aβ负担之间的联系.
研究的目的:
- 为了研究白质微观结构的纵向变化与唐氏综合征的成年人中的粉样β负担之间的关系.
- 确定DTI是否可以作为DS中与粉样蛋白积累相关的神经退行症的敏感生物标志物.
主要方法:
- 长度粉样蛋白匹兹堡化合物B正子发射断层扫描 (PET) 和DTI数据从35名DS成年人 (年龄25-57岁) 中收集.
- 分析了百叶状体 (CL) 值和DTI参数 (异异性,扩散性).
- 基于路径的空间统计和排列分析确定了CL和DTI指标变化速率之间的相关性.
主要成果:
- 在DTI参数的纵向变化率和Aβ负担之间发现了显著的相关性.
- 关键受影响的区域包括体,冠状辐射和长联纤维.
- 与横截面分析相比,纵向分析揭示了更显著的变化区域.
结论:
- 粉样β负担与唐氏综合征的成年人广泛的纵向白质微观结构变化有关.
- 这些发现表明,白质变化是DS中粉样蛋白积累过程中不可或缺的一部分.
- DTI和粉样-PET成像提供了敏感的方法来跟踪DS的微观结构和病理变化.
相关概念视频
01:17Assessment of Diffusion and Perfusion
2.0K
Understanding and evaluating diffusion and perfusion is critical in assessing a patient's respiratory and circulatory health. These processes play key roles in maintaining the body's internal environment, ensuring that tissues receive adequate oxygen while waste products are efficiently removed.
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
2.0K
01:29Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21